High-throughput screening of expressed DNA libraries in filamentous fungi

Details for Australian Patent Application No. 2006249202 (hide)

Owner Emalfarb, M.

Inventors Not Given

Agent Griffith Hack

Pub. Number AU-A-2006249202

Parent 53544

Filing date 1 December 2006

Wipo publication date 4 January 2007

International Classifications

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 1/00 (2006.01) Micro-organisms, e.g. protozoa

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 1/04 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Determining presence or kind of micro-organism

C12R 1/645 (2006.01)

Event Publications

21 December 2006 Complete Application Filed

4 January 2007 Application Open to Public Inspection

  Published as AU-A-2006249202

8 January 2009 Assignment before Grant

  Emalfarb, Mark The application has been assigned to Dyadic International (USA), Inc.

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006249203-Improved device for the remote control of a fire arm

2006249199-P53 vaccines for the treatment of cancers